Pfizer Inc (PFE)
26.02
-0.70
(-2.62%)
USD |
NYSE |
Nov 14, 16:00
25.64
-0.38
(-1.46%)
Pre-Market: 08:53
Pfizer Unrealized Gain or Loss - Total (Quarterly)
Unrealized Gain or Loss - Total (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Unrealized Gain or Loss - Total (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -- |
| June 30, 2024 | -- |
| March 31, 2024 | -- |
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| Date | Value |
|---|---|
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
Unrealized Gain or Loss Definition
Unrealized Gain or Loss is the change in value of the assets or liabilities held by a company that haven't yet been realized through a transaction. These gains or losses are present on a company's balance sheet but have not resulted from an actual sale. A positive Unrealized Gain or Loss value indicates that the company holds assets that have appreciated in value but have not yet be realized. A negative Unrealized Gain or Loss indicates that the company holds an asset or investment whose valu...
Unrealized Gain or Loss - Total (Quarterly) Range, Past 5 Years
Unrealized Gain or Loss - Total (Quarterly) Benchmarks
| Amgen Inc | -- |
| Johnson & Johnson | -- |
| Eli Lilly and Co | -- |
| Merck & Co Inc | -- |
| Moderna Inc | -- |